Evolus (EOLS) Gains from Investment Securities (2017 - 2026)
Evolus (EOLS) reported Gains from Investment Securities of $4000.0 for Q1 2026, up 100.09% quarter-over-quarter from -$4.5 million in Q4 2025.
Evolus (EOLS) Gains from Investment Securities (2017 - 2026) Analysis & Trends
Evolus has reported Gains from Investment Securities for 10 years, with the latest figure at $4000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities changed N/A year-over-year to $4000.0; the trailing twelve-month figure through Mar 2026 stood at -$6.4 million (down 188.87% YoY), and the FY2025 full-year result was -$6.4 million, down 188.92% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $4000.0, up from -$4.5 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $7.2 million in Q4 2024, with the low at -$4.5 million in Q4 2025.
- Historically, Gains from Investment Securities has averaged $65428.6 across 5 years, with a median of $17000.0 in 2023.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities jumped 6016.67% — and 2025, when it slumped 1044.51%.
- Evolus' Gains from Investment Securities stood at -$3.9 million in 2022, then declined by 12.34% to -$4.4 million in 2023, then soared by 261.88% to $7.2 million in 2024, then sank by 162.86% to -$4.5 million in 2025, then jumped by 100.09% to $4000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $4000.0 (Q1 2026), -$4.5 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Evolus | 439.03 Mn | 389.24 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | -4.51 Mn |
| Dec 31, 2025 | -4.51 Mn |
| Sep 30, 2025 | -1.88 Mn |
| Sep 30, 2025 | -1.88 Mn |
| Jun 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Dec 31, 2024 | 7.18 Mn |
| Dec 31, 2024 | 7.18 Mn |
| Sep 30, 2024 | -164,000.00 |
| Sep 30, 2024 | -164,000.00 |
| Jun 30, 2024 | 164,000.00 |
| Jun 30, 2024 | 164,000.00 |
| Dec 31, 2023 | -4.43 Mn |
| Dec 31, 2023 | -4.43 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Jun 30, 2023 | 3.30 Mn |